SCHEMBL7014244

SCHEMBL7014244

Cc1ccc(S(=O)(=O)n2cc(I)c(N)nc2=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 2/20 0.45
NOD1 Q9Y239 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 2/20 0.43
ALDH3A1 P30838 1/20 0.43
HTT P42858 1/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
RAPGEF4 Q8WZA2 1/20 0.41
CXCL8 P10145 1/20 0.41
GAA P10253 1/20 0.41
NOD2 Q9HC29 1/20 0.41
TSHR P16473 1/20 0.41
MMP2 P08253 1/20 0.40
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010844 0.83 CA1 (0.55) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL12900477 0.83 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL7016019 0.75 L3MBTL1 (0.50) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL31052299 0.74 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL30120753 0.73 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL12696218 0.72 CA1 (0.49) MEN1KMT2AMAPTALDH1A1NOD1
SCHEMBL31052310 0.72 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL12900467 0.71 DCK (0.43) ALDH1A1LMNAPOLB
SCHEMBL31006563 0.71 L3MBTL1 (0.44) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL29283857 0.71 L3MBTL1 (0.44) MEN1KMT2AMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0877022-B1 Sulfonylpyrimidine derivatives with anticancer activity RUDJER BOSKOVIC INST (HR) 2003-04-16 EP claimed
EP-0877022-A1 Synthesis of the sulfonylpyrimidine derivatives with anticancer activity Herbos d.d. (HR) 1998-11-11 EP claimed
EP-0877022-A1 Synthesis of the sulfonylpyrimidine derivatives with anticancer activity Herbos d.d. (HR) 1998-11-11 EP disclosed